Comparative efficacy of Chinese-developed versus imported PD-1/PD-L1 inhibitors in first-line combination therapy for advanced NSCLC: a systematic review and network meta-analysis

Journal of the National Cancer Center · Elsevier

Аннотация

Publication date: Available online 7 June 2026 Source: Journal of the National Cancer Center Author(s): Jingting Yang, Rui Min, Hongcheng Zhong, Chihua Li, Yuan-Jia Hu

Читать у издателя →

Похожие статьи